PD1 signal transduction pathways in T cells
dc.contributor.author | Arasanz Esteban, Hugo | |
dc.contributor.author | Gato Cañas, María | |
dc.contributor.author | Zuazo Ibarra, Miren | |
dc.contributor.author | Ibañez Vea, María | |
dc.contributor.author | Breckpot, Karine | |
dc.contributor.author | Kochan, Grazyna | |
dc.contributor.author | Escors Murugarren, David | |
dc.contributor.department | Ciencias de la Salud | es_ES |
dc.contributor.department | Osasun Zientziak | eu |
dc.contributor.funder | Gobierno de Navarra / Nafarroako Gobernua | es |
dc.date.accessioned | 2022-08-08T11:34:49Z | |
dc.date.available | 2022-08-08T11:34:49Z | |
dc.date.issued | 2017 | |
dc.date.updated | 2022-08-08T11:05:17Z | |
dc.description.abstract | The use of immune checkpoint inhibitors for the treatment of cancer is revolutionizing oncology. Amongst these therapeutic agents, antibodies that block PD-L1/PD1 interactions between cancer cells and T cells are demonstrating high efficacies and low toxicities. Despite all the recent advances, very little is yet known on the molecular intracellular signaling pathways regulated by either PD-L1 or PD1. Here we review the current knowledge on PD1-dependent intracellular signaling pathways, and the consequences of disrupting PD1 signal transduction. | en |
dc.description.sponsorship | MGC is funded by a Government of Navarre PhD fellowship (BMED 033-2014); MZ is funded by a Gobierno de Navarra Project grant (GN 33/14) and a ‘Precipita’ crowdfunding project grant from Fundación Española para la Ciencia y la Tecnología (FECYT). MIV is funded by a Sara Borrel post-doctoral fellowship. DE is funded by a 'Miguel Servet' Fellowship (CP12/03114) from the Instituto de Salud Carlos III (ISCIII), Spain. GK is funded by a ‘Proyecto Tractor ProCel’ from the Government of Navarre. The authors gratefully acknowledge the ‘Sandra Ibarra’ Foundation, the ‘Navarrese Association against Breast Cancer’ (SARAY), ‘Caixa Foundation’ and ISCIII (FIS. PI14/00579 project grant) for their financial support. | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Arasanz, H.; Gato-Cañas, M.; Zuazo, M.; Ibáñez-Vea, M.; Breckpot, K.; Kochan, G.; Escors, D.. (2017). PD1 signal transduction pathways in T cells. Oncotarget. 8,31, pp. 51936-51945 | en |
dc.identifier.doi | 10.18632/oncotarget | |
dc.identifier.issn | 1949-2553 | |
dc.identifier.uri | https://academica-e.unavarra.es/handle/2454/43708 | |
dc.language.iso | eng | en |
dc.publisher | Impact Journals | en |
dc.relation.ispartof | Oncotarget, 2017, 8 (31), pp. 51936-51945 | en |
dc.relation.publisherversion | https://doi.org/10.18632/oncotarget | |
dc.rights | © Arasanz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 | en |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by/3.0/ | |
dc.subject | PD-L1 | en |
dc.subject | PDL1 | en |
dc.subject | PD1 | en |
dc.subject | B7-H1 | en |
dc.subject | Cancer | en |
dc.title | PD1 signal transduction pathways in T cells | en |
dc.type | info:eu-repo/semantics/article | |
dc.type.version | info:eu-repo/semantics/publishedVersion | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 193d800d-c38c-4627-b9d8-d29435d8214c | |
relation.isAuthorOfPublication | f96114c2-9fc5-4886-ab9a-4804f14aa9c6 | |
relation.isAuthorOfPublication.latestForDiscovery | 193d800d-c38c-4627-b9d8-d29435d8214c |